{"count": 4, "results": [{"_id": "34660791", "pmid": 34660791, "pmcid": "PMC8519697", "title": "The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis", "journal": "Biomed Res Int", "authors": ["Yao X", "Liu H", "Xu H"], "date": "2021-10-08T00:00:00Z", "doi": "10.1155/2021/5311828", "meta_date_publication": "2021", "meta_volume": "2021", "meta_issue": "", "meta_pages": "5311828", "score": 50287.62, "text_hl": "The Impact of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Use with Survival Outcomes in @<m>DISEASE_Urologic_Neoplasms</m> @DISEASE_MESH:D014571 @@@Urologic Cancers@@@: A Systematic Review and Meta-Analysis", "citations": {"NLM": "Yao X, Liu H, Xu H. The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis Biomed Res Int. 2021;2021():5311828. PMID: 34660791", "BibTeX": "@article{34660791, title={The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis}, author={Yao X and Liu H and Xu H}, journal={Biomed Res Int}, volume={2021}, pages={5311828}}"}}, {"_id": "36906272", "pmid": 36906272, "title": "New insight in urological cancer therapy: From epithelial-mesenchymal transition (EMT) to application of nano-biomaterials.", "journal": "Environ Res", "authors": ["He P", "Dai Q", "Wu X"], "date": "2023-03-10T00:00:00Z", "doi": "10.1016/j.envres.2023.115672", "meta_date_publication": "2023 Mar 10", "meta_volume": "229", "meta_issue": "", "meta_pages": "115672", "score": 50254.34, "text_hl": "Moreover, anti-@DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ compounds such as @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can be utilized in suppressing @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@malignancy of@@@ @<m>DISEASE_Urologic_Neoplasms</m> @DISEASE_MESH:D014571 @@@urological tumors@@@. ", "citations": {"NLM": "He P, Dai Q, Wu X. New insight in urological cancer therapy: From epithelial-mesenchymal transition (EMT) to application of nano-biomaterials. Environ Res. 2023 Mar 10;229():115672. PMID: 36906272", "BibTeX": "@article{36906272, title={New insight in urological cancer therapy: From epithelial-mesenchymal transition (EMT) to application of nano-biomaterials.}, author={He P and Dai Q and Wu X}, journal={Environ Res}, volume={229}, pages={115672}}"}}, {"_id": "27195314", "pmid": 27195314, "pmcid": "PMC4869570", "title": "Potential role for metformin in urologic oncology", "journal": "Investig Clin Urol", "authors": ["Sayyid RK", "Fleshner NE"], "date": "2016-05-01T00:00:00Z", "doi": "10.4111/icu.2016.57.3.157", "meta_date_publication": "2016 May", "meta_volume": "57", "meta_issue": "3", "meta_pages": "157-64", "score": 50068.695, "text_hl": "These studies suggest that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ does have a future role in the prevention and management of @<m>DISEASE_Urologic_Neoplasms</m> @DISEASE_MESH:D014571 @@@urologic malignancies@@@. ", "citations": {"NLM": "Sayyid RK, Fleshner NE. Potential role for metformin in urologic oncology Investig Clin Urol. 2016 May;57(3):157-64. PMID: 27195314", "BibTeX": "@article{27195314, title={Potential role for metformin in urologic oncology}, author={Sayyid RK and Fleshner NE}, journal={Investig Clin Urol}, volume={57}, number={3}, pages={157-64}}"}}, {"_id": "26969242", "pmid": 26969242, "title": "Diabetes Mellitus Type 2: A Driving Force for Urological Complications.", "journal": "Trends Endocrinol Metab", "authors": ["Sayyid RK", "Fleshner NE"], "date": "2016-05-01T00:00:00Z", "doi": "10.1016/j.tem.2016.02.006", "meta_date_publication": "2016 May", "meta_volume": "27", "meta_issue": "5", "meta_pages": "249-261", "score": 50042.414, "text_hl": "Previously unknown associations between @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@ and risk for @DISEASE_Prostatic_Neoplasms @DISEASE_MESH:D011471 @@@prostate cancer@@@, @DISEASE_Urinary_Bladder_Neoplasms @DISEASE_MESH:D001749 @@@bladder cancer@@@, @DISEASE_Carcinoma_Renal_Cell @DISEASE_MESH:D002292 @@@renal cell carcinomas@@@, @DISEASE_Urinary_Tract_Infections @DISEASE_MESH:D014552 @@@urinary tract infections@@@, @DISEASE_Nephrolithiasis @DISEASE_MESH:D053040 @@@nephrolithiasis@@@, @DISEASE_Penile_Diseases @DISEASE_MESH:D010409 @@@penile lesions@@@, @DISEASE_Virilism @DISEASE_MESH:D014770 @@@androgen deficiency@@@, and @DISEASE_Erectile_Dysfunction @DISEASE_MESH:D007172 @@@erectile dysfunction@@@ have been discovered. Significantly, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ could play a role in the management of @<m>DISEASE_Urologic_Neoplasms</m> @DISEASE_MESH:D014571 @@@urological malignancies@@@, and therapies used for management of these @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancers@@@ could in return lead to increased risk for @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@. ", "citations": {"NLM": "Sayyid RK, Fleshner NE. Diabetes Mellitus Type 2: A Driving Force for Urological Complications. Trends Endocrinol Metab. 2016 May;27(5):249-261. PMID: 26969242", "BibTeX": "@article{26969242, title={Diabetes Mellitus Type 2: A Driving Force for Urological Complications.}, author={Sayyid RK and Fleshner NE}, journal={Trends Endocrinol Metab}, volume={27}, number={5}, pages={249-261}}"}}]}